close 73% jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 73% jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse. Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
Change languageEesti
Ülevaade

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

Kodu・Aktsiate loetelu・Nektar Therapeutics
Search

Nektar Therapeutics

Suletud

65.42 8.15

Osta

Hinna uuendus 26. nov 2025, 20:59 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

65.22

Max

66.41

Põhinäitajad

By Trading Economics

Sissetulek

6.1M

-36M

Müük

615K

12M

Aktsiakasum

-1.87

Kasumimarginaal

-301.289

Töötajad

61

EBITDA

6.9M

-29M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+48.62% upside

Turustatistika

By TradingEconomics

Turukapital

53M

1.2B

Eelmine avamishind

57.27

Eelmine sulgemishind

65.42

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

0.5949 / 0.7406 Toetus ja vastupanu

Nektar Therapeutics Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

27. nov 2025, 16:49 UTC

Omandamised, ülevõtmised, äriostud

Deutsche Boerse in Talks to Buy Fund-Tech Platform Allfunds in $6 Billion Deal

DJ

Loe

27. nov 2025, 15:32 UTC

Omandamised, ülevõtmised, äriostud

TotalEnergies, Repsol in Talks to Combine U.K. North Sea Assets, Cinco Dias Says, Citing Sources

DJ

Loe

27. nov 2025, 23:50 UTC

Market Talk

Nikkei May Trade Rangebound Amid Caution Over Economic Outlook -- Market Talk

DJ

Loe

27. nov 2025, 23:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Loe

27. nov 2025, 16:05 UTC

Market Talk

Canadian Job Vacancies Rise for Fist Time Since Start of 2024 -- Market Talk

DJ

Loe

27. nov 2025, 16:04 UTC

Market Talk

Canadian Payroll Employment Pulls Back in September, Offsetting Recent Gains -- Market Talk

DJ

Loe

27. nov 2025, 15:54 UTC

Omandamised, ülevõtmised, äriostud

Allfunds Shares Rise 21% After Deutsche Boerse Says Started Acquisition Talks

DJ

Loe

27. nov 2025, 15:44 UTC

Omandamised, ülevõtmised, äriostud

Deutsche Boerse: No Certainty Talks Will Result in Transaction

DJ

Loe

27. nov 2025, 15:43 UTC

Omandamised, ülevõtmised, äriostud

Deutsche Boerse: Allfunds Board of Directors Has Agreed to Enter Exclusive Talks

DJ

Loe

27. nov 2025, 15:42 UTC

Omandamised, ülevõtmised, äriostud

Deutsche Boerse: Nonbinding Proposal is To Acquire Allfunds at EUR8.80 a Share

DJ

Loe

27. nov 2025, 15:41 UTC

Omandamised, ülevõtmised, äriostud

Deutsche Boerse in Talks With Allfunds on Possible Acquisition

DJ

Loe

27. nov 2025, 15:11 UTC

Market Talk

Dollar Could Fall in 2026 as U.S. Rate Cuts Bite -- Market Talk

DJ

Loe

27. nov 2025, 14:26 UTC

Market Talk

Hermes' Outperformance Gap Could Narrow -- Market Talk

DJ

Loe

27. nov 2025, 14:11 UTC

Market Talk

Lack of Major Budget Surprises Don't Justify Continued Sterling Strength -- Market Talk

DJ

Loe

27. nov 2025, 14:11 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

DJ

Loe

27. nov 2025, 13:35 UTC

Market Talk

Richemont Looks Set to Continue Outgrowing Peers -- Market Talk

DJ

Loe

27. nov 2025, 13:33 UTC

Market Talk

Sterling's Post-Budget Gains Are Probably Over -- Market Talk

DJ

Loe

27. nov 2025, 13:22 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Loe

27. nov 2025, 13:22 UTC

Market Talk

Kering's Plan to Revive Gucci Needs More Clarity -- Market Talk

DJ

Loe

27. nov 2025, 13:17 UTC

Market Talk

LVMH Should Be Able to Recover Next Year -- Market Talk

DJ

Loe

27. nov 2025, 11:13 UTC

Market Talk

European Gas Prices Come Under Pressure -- Market Talk

DJ

Loe

27. nov 2025, 11:07 UTC

Tulu

Genting: Positive About Prospects Over Longer Term

DJ

Loe

27. nov 2025, 11:06 UTC

Tulu

Genting: Cautious on Near-Term Prospects of Leisure, Hospitality Industry

DJ

Loe

27. nov 2025, 11:04 UTC

Tulu

Genting: International Travel Demand Expected to Remain Resilient

DJ

Loe

27. nov 2025, 11:04 UTC

Tulu

Genting: Global Growth Expected to Remain Subdued

DJ

Loe

27. nov 2025, 11:04 UTC

Tulu

Genting: Ebitda Partly Weighed by Stronger Ringgit Vs. Singapore Dollar, British Pound, U.S. Dollar

DJ

Loe

27. nov 2025, 10:59 UTC

Tulu

Genting Bhd 3Q Net Profit Fell 86% on Year

DJ

Loe

27. nov 2025, 10:58 UTC

Tulu

Genting Bhd 3Q Rev Rose 14% on Year

DJ

Loe

27. nov 2025, 10:56 UTC

Tulu

Genting Bhd 3Q Net MYR30.3M

DJ

Loe

27. nov 2025, 10:56 UTC

Tulu

Genting Bhd 3Q EPS MYR0.0079

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

Nektar Therapeutics Prognoos

Hinnasiht

By TipRanks

48.62% tõus

12 kuu keskmine prognoos

Keskmine 97.63 USD  48.62%

Kõrge 121 USD

Madal 30 USD

Põhineb 9 Wall Streeti analüütiku instrumendi Nektar Therapeutics 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

9 ratings

7

Osta

1

Hoia

1

Müü

Põhineb 9 analüütiku instrumendi Nektar Therapeutics aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

0.5949 / 0.7406Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Keskpikk perspektiiv

Strong Bearish Evidence

All events are bearish.

Pikk perspektiiv

Bearish Evidence

All events are bearish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Muud aktsiad sektorist

LLY

Eli Lilly and Co.

1,105.05

↓-0.35%

JNJ

Johnson and Johnson

207.73

↑ +0.45%

ABBV

AbbVie Inc

227.54

↓-1.85%

UNH

UnitedHealth Group Inc

329.68

↑ +1.07%

AZN

AstraZeneca PLC ADR

93.37

↑ +0.12%
help-icon Live chat